Drug accumulation in Sprague-Dawley rat thalamus at 350 uCi, iv pre-injected with 1 mg/kg haloperidol 5 mins before compound injection measured 60 mins post compound dose by ex vivo autoradiography
Drug accumulation in Sprague-Dawley rat hypothalamus at 350 uCi, iv pre-injected with 1 mg/kg haloperidol 5 mins before compound injection measured 60 mins post compound dose by ex vivo autoradiography
Drug accumulation in Sprague-Dawley rat midbrain at 350 uCi, iv pre-injected with 1 mg/kg haloperidol 5 mins before compound injection measured 60 mins post compound dose by ex vivo autoradiography
Drug accumulation in Sprague-Dawley rat cortex at 350 uCi, iv pre-injected with 1 mg/kg haloperidol 5 mins before compound injection measured 60 mins post compound dose by ex vivo autoradiography
Drug accumulation in Sprague-Dawley rat cerebellum at 350 uCi, iv pre-injected with 1 mg/kg haloperidol 5 mins before compound injection measured 60 mins post compound dose by ex vivo autoradiography
Drug accumulation in Sprague-Dawley rat facial nucleus at 350 uCi, iv pre-injected with 1 mg/kg haloperidol 5 mins before compound injection measured 60 mins post compound dose by ex vivo autoradiography
Biodistribution in ICR mouse bone at 4 uCi, iv pre-injected with 1 mg/kg haloperidol 5 mins before compound injection measured 60 mins post compound dose (Rvb = 2.80 +/- 0.13 %ID/g of tissue)
Biodistribution in ICR mouse small intestine assessed as compound level per organ at 4 uCi, iv pre-injected with 1 mg/kg haloperidol 5 mins before compound injection measured 60 mins post compound dose (Rvb = 8.05 +/- 2.41 %ID per organ)
Biodistribution in ICR mouse stomach assessed as compound level per organ at 4 uCi, iv pre-injected with 1 mg/kg haloperidol 5 mins before compound injection measured 60 mins post compound dose (Rvb = 1.33 +/- 0.17 %ID per organ)